A Phase 1 Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TNP-2092 Capsules, and the Food Effect on the Pharmacokinetics of TNP-2092 Capsules After Single-dose Oral Administration in Healthy Subjects
Latest Information Update: 05 May 2025
At a glance
- Drugs Rifaquizinone (Primary)
- Indications Hyperammonaemia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors TenNor Therapeutics
Most Recent Events
- 25 Dec 2023 New trial record